Open access
Sep 2026
A Single Suprachoroidal Injection of AXT107 (Gersizangitide), a Multimodal, Long-Acting Integrin-Disrupting Peptide, in Patients with Neovascular Age-Related Macular Degeneration: Results of the Phase 1/2a DISCOVER Trial
Niranjan B. Pandey, Adam C. Mirando, David R. P. Almeida et al.
· medRxiv · 0 citations